The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies.
Open accessAbstract
The primary anti-phospholipid syndrome is characterized by recurrent venous and arterial thromboembolic phenomena, recurrent fetal loss, thrombocytopenia, and serological evidence of anti-cardiolipin (aCL) antibodies or/and the presence of lupus anticoagulant (prolonged activated partial thromboplastin time). The exact role of aCL antibodies in pathogenesis is not clear and the mechanism by which the antibodies may induce the various manifestations is unknown. In the current study we evaluated the effect of passive transfer of aCL antibodies (to the tail vein of naive mice) on fecundity, fetal loss (fetal resorption), and the weight of embryos and placentae. Two types of aCL antibodies were employed: (i) mouse monoclonal aCL antibodies derived from a BALB/c mouse in which experimental systemic lupus erythematosus was induced by a pathogenic idiotype (idiotype 16/6) of anti-DNA antibodies and (ii) polyclonal IgG and IgM aCL antibodies derived from serum of a patient with primary anti-phospholipid syndrome. After infusion of either antibody (10 micrograms per mouse) we could demonstrate lower fecundity rate, increased resorption index of embryos (equivalent to recurrent fetal loss), lower number of embryos per pregnancy, and lower mean weights of embryos and placentae in comparison to mice infused with appropriate control immunoglobulins. We conclude that the aCL antibodies may have direct effects on fecundity and on the outcome of pregnancy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The 1982 revised criteria for the classification of systemic lupus erythematosus
Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., Mcshane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., & Winchester, R. J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780251101 · Cited by 14,519
The "primary" antiphospholipid syndrome: major clinical and serological features.
Asherson, R. A., Khamashta, M. A., Ordi‐Ros, J., Derksen, R. H. W. M., Machin, S. J., Barquinero, J., OUTT, H. H., Harris, E. N., Vilardell, M., & Hughes, G. R. V. (1989) · PubMed · Cited by 892
(1963) · PubMed · Cited by 512
Primary Antiphospholipid Syndrome
(2020) · Frontiers Research Topics · doi:10.3389/978-2-88966-108-4 · Cited by 346
Thromboembolism in Patients With the 'Lupus'-Type Circulating Anticoagulant
Elias, M. S. (1984) · Archives of Internal Medicine · doi:10.1001/archinte.144.3.510 · Cited by 322
Mendlovic, S., Brocke, S., Shoenfeld, Y., Ben-Bassat, M., Meshorer, A., Bakimer, R., & Mozes, E. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.7.2260 · Cited by 297
Self-citationLupus anticoagulant: An analysis of the clinical and laboratory features of 219 cases
Gastineau, D. A., Kazmier, F. J., Nichols, W. L., & Bowie, E. J. W. (1985) · American Journal of Hematology · doi:10.1002/ajh.2830190308 · Cited by 257
Mackworth-Young, C. G., Loizou, S., & Walport, M. J. (1989) · Annals of the Rheumatic Diseases · doi:10.1136/ard.48.5.362 · Cited by 243
Immunologic and Coagulation Disorders in Chlorpromazine-Treated Patients
ZARRABI, M. H., ZUCKER, S., MILLER, F., DERMAN, R. M., ROMANO, G. S., HARTNETT, J. A., & VARMA, A. O. (1979) · Annals of Internal Medicine · doi:10.7326/0003-4819-91-2-194 · Cited by 231
Anticardiolipin response in acute infections
Vaarala, O., Palosuo, T., Kleemola, M., & Aho, K. (1986) · Clinical Immunology and Immunopathology · doi:10.1016/0090-1229(86)90046-2 · Cited by 231
Immune mediated mechanism for thrombosis: antiphospholipid antibody binding to platelet membranes.
Khamashta, M. A., Harris, E. N., Gharavi, A. E., Derue, G., Gil, A., Vázquez, J. J., & Hughes, G. R. (1988) · Annals of the Rheumatic Diseases · doi:10.1136/ard.47.10.849 · Cited by 226
Anticardiolipin antibodies in autoimmune thrombocytopenic purpura
Harris, E. N., Gharavi, A. E., Hegde, U., Derue, G., Morgan, S. H., Englert, H., Chan, J. K. H., Asherson, R. A., & Hughes, G. R. V. (1985) · British Journal of Haematology · doi:10.1111/j.1365-2141.1985.tb02989.x · Cited by 219
Lupus Anticoagulants and Thrombosis
Lechner, K., & Pabinger-Fasching, I. (1985) · Pathophysiology of Haemostasis and Thrombosis · doi:10.1159/000215157 · Cited by 192
Thrombosis in Systemic Lupus Erythematosus: Relation to the Presence of Circulating Anticoagulants
Glueck, H. I. (1985) · Archives of Internal Medicine · doi:10.1001/archinte.1985.00360080059007 · Cited by 191
Circulating Coagulation Inhibitors in the Acquired Immunodeficiency Syndrome
COHEN, A. J., PHILIPS, T. M., & KESSLER, C. M. (1986) · Annals of Internal Medicine · doi:10.7326/0003-4819-104-2-175 · Cited by 183
Reproductive failure because of autoantibodies: Unexplained infertility and pregnancy wastage
Gleicher, N., El-Roeiy, A., Confino, E., & Friberg, J. (1989) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(89)90858-2 · Cited by 162
Prekallikrein Inhibition Associated with the Lupus Anticoagulant: A Mechanism of Thrombosis
Sanfelippo, M. J., & Drayna, C. J. (1982) · American Journal of Clinical Pathology · doi:10.1093/ajcp/77.3.275 · Cited by 146
Chlorpromazine‐induced lupus anticoagulant and associated immunologic abnormalities
Canoso, R. T., & Sise, H. S. (1982) · American Journal of Hematology · doi:10.1002/ajh.2830130204 · Cited by 138
Peripheral Vascular Syndromes Associated with Systemic Lupus Erythematosus
Alarcón-Segovia, D., & OSMUNDSON, P. J. (1965) · Annals of Internal Medicine · doi:10.7326/0003-4819-62-5-907 · Cited by 89
Antiphospholipid Antibodies and Reproduction
Triplett, D. A., & Harris, E. N. (1989) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.1989.tb01016.x · Cited by 81
A reassessment of the antiphospholipid syndrome.
Harris, E. N. (1990) · PubMed · Cited by 63
ANTICARDIOLIPIN ANTIBODIES IN RHEUMATOID ARTHRITIS
KEANE, A., WOODS, R., Dowding, V. M., Roden, D., & BARRY, C. (1987) · Lara D. Veeken · doi:10.1093/rheumatology/26.5.346 · Cited by 56
Fetal loss treatment in patients with antiphospholipid antibodies.
Ordi‐Ros, J., Barquinero, J., Vilardell, M., Jordana, R., Tolosa-Vilella, C., Selva-O’Callaghan, A., & Genover, E. (1989) · Annals of the Rheumatic Diseases · doi:10.1136/ard.48.10.798 · Cited by 46
LUPUS ANTICOAGULANT AND THROMBOSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS
Jungers, P., Lioté, F., Dautzenberg, M., Gazengel, C., Dougados, M., Tron, F., & Bach, J. (1984) · The Lancet · doi:10.1016/s0140-6736(84)90982-6 · Cited by 46
Delezé, M., Alarcón-Segovia, D., Macho, E. V., Oria, C. V., & de Leon, S. P. (1989) · PubMed · Cited by 46
Dührsen, U., Paar, D., Kölbel, C., Boekstegers, A., Metz-Kurschel, U., Wagner, R. A., Kirch, W., Meusers, P., König, E., & Brittinger, G. (1987) · Journal of Molecular Medicine · doi:10.1007/bf01737004 · Cited by 23
Cited by
The biosynthesis and functional role of cardiolipin
Schlame, M., Rua, D., & Greenberg, M. L. (2000) · Progress in Lipid Research · doi:10.1016/s0163-7827(00)00005-9 · Cited by 810
Guidelines on the investigation and management of antiphospholipid syndrome
Keeling, D., Mackie, I., Moore, G. W., Greer, I. A., Greaves, M., & British Committee for Standards in Haematology (2012) · British Journal of Haematology · doi:10.1111/j.1365-2141.2012.09037.x · Cited by 740
Heparin prevents antiphospholipid antibody–induced fetal loss by inhibiting complement activation
Girardi, G., Redecha, P., & Salmon, J. E. (2004) · Nature Medicine · doi:10.1038/nm1121 · Cited by 680
Complement C3 Activation Is Required for Antiphospholipid Antibody-induced Fetal Loss
Holers, V. M., Girardi, G., Mo, L., Guthridge, J. M., Molina, H., Pierangeli, S. S., Espinola, R., Xiaowei, L. E., Mao, D., Vialpando, C. G., et al. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.200116116 · Cited by 626
Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome
Girardi, G., Berman, J., Redecha, P., Spruce, L., Thurman, J. M., Kraus, D., Hollmann, T. J., Casali, P., Caroll, M. C., Wetsel, R. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200318817 · Cited by 594
Metadata
- Authors
- Blank, M., Cohen, J., Toder, V, & Shoenfeld, Y.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1991-04-15
- Volume
- 88
- Issue
- 8
- Pages
- 3069-3073
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2074332508
- Cited by
- 455
- References
- 26
- FWCI
- 21.06
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.